Pharmaceuticals Business

Nippon Kayaku's history of anti-cancer drugs began with the launch of BREO® in 1969, and has various product lineup of many anti-cancer drugs. On the basis of Nippon Kayaku's network of cancer-specialist medical representatives, highly reliable information can be rapidly provided to physicians, pharmacists and nurses at clinical institutions. In recent years, we have been furthering our efforts into the areas of biosimilar products, generic anti-cancer drugs, as well as medical device so that we can continue to provide highly necessary pharmaceuticals and medical device for patients along with exceptionally reliable information to the medical institutions.

We will continue to develop outstanding pharmaceuticals and medical devices, provide new diagnostic and therapeutic opportunities, and have a stable supply of biosimilars and generics, thereby contributing to the realization of sustainable society and people's health.


Business Overview

Related Information

Our Business

Our Business
Corporate Information
Global Netowork
Investor Relations